Company Shanghai Yizhong Pharmaceutical Co., Ltd.

688091

CNE1000050F4

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Specialty & Advanced Pharmaceuticals

SHANGHAI YIZHONG PHARMACEUTICAL CO., LTD.

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-07 pm EDT			5-day change	1st Jan Change
39.71 ^CNY	+0.97%		+6.12%	-37.95%

Apr. 30	Mainland China stocks edge lower ahead of long Labor Day holiday, Hong Kong rises	RE
Apr. 29	Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Shanghai Yizhong Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development and industrialization of new and improved anti-tumor drugs. The Company's main products include paclitaxel micelles, docetaxel micelles and cabazitaxel micelles. Paclitaxel micelles are products under development that have been submitted for registration and marketing applications, and their indications are non-small cell lung cancer. Docetaxel micelles and cabazitaxel micelles are products under development in the pre-clinical research stage.

Number of employees: 304

CNY in Million	2022	Weight	2023	Weight	Delta
Chemical and Pharmaceutical 100.0 %	236	100.0 %	360	100.0 %	+52.68%

CNY in Million	2022	Weight	2023	Weight	Delta
China 100.0 %	236	100.0 %	360	100.0 %	+52.68%

Managers	Title	Age	Since
Duan Li FOU	Founder	84	09-09-09
Jin Song Zhou CEO	Chief Executive Officer	56	09-09-09
Ruo Yun Pan CHM	Chairman	43	17-07-31
Xin Ran Meng BRD	Director/Board Member	31	19-04-30
Jing Sun BRD	Director/Board Member	47	09-09-30
Zhou Fang SEC	Corporate Secretary	36	18-05-31

Members of the board	Title	Age	Since
Jin Song Zhou CEO	Chief Executive Officer	56	09-09-09
Duan Li FOU	Founder	84	09-09-09
Jing Sun BRD	Director/Board Member	47	09-09-30
Xue Hang Du BRD	Director/Board Member	56	16-02-29
Yan Ren Xiong BRD	Director/Board Member	52	20-03-08
Gai Rong Hu BRD	Director/Board Member	47	20-03-08
Chun Meng Sun BRD	Director/Board Member	39	20-03-08
Ruo Yun Pan CHM	Chairman	43	17-07-31
Xin Ran Meng BRD	Director/Board Member	31	19-04-30

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	158,276,800	63,604,284 ( 40.19 %)	0	40.19 %

Name	Equities	%	Valuation
SHANGHAI KAIBAO PHARMACEUTICAL CO.,LTD 16.39 %	19,002,728	16.39 %	113 M ¥
Feng Li 4.645 %	5,385,600	4.645 %	32 M ¥
Duan Li 4.621 %	5,357,176	4.621 %	32 M ¥
Shanghai Xianyu Investment LP 4.609 %	5,343,800	4.609 %	32 M ¥
Xun Li 4.498 %	5,214,671	4.498 %	31 M ¥
Shanghai Jianxin Healthcare Investment Management Co. Ltd. 2.903 %	3,366,000	2.903 %	20 M ¥
Yu Sheng Zhao 2.800 %	3,246,320	2.800 %	19 M ¥
Shanghai Yixian Health Management Consulting LP 2.696 %	3,126,066	2.696 %	19 M ¥
Yuan Zhang 2.352 %	2,726,770	2.352 %	16 M ¥
Mei Hua Zeng 1.931 %	2,239,380	1.931 %	13 M ¥

Name	Equities	%	Valuation
Jin Song Zhou 80.20 %	30,866,968	80.20 %	183 M ¥
Shanghai Shanyuan Enterprise Management LP 19.44 %	7,480,000	19.44 %	44 M ¥
Shanghai Yixing Enterprise Management LP 9.718 %	3,740,000	9.718 %	22 M ¥

Shanghai Yizhong Pharmaceutical Co., Ltd.

79 Renqi Road Fengxian District

201403, Shanghai

http://www.yizhongpharma.com

address Shanghai Yizhong Pharmaceutical Co., Ltd.(688091)

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Specialty & Advanced Pharmaceuticals

	1st Jan change	Capi.
SHANGHAI YIZHONG PHARMACEUTICAL CO., LTD.	-37.95%	863M
MERCK KGAA	+6.97%	71.94B
SK BIOPHARMACEUTICALS CO., LTD.	-10.86%	5.13B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	+46.43%	4.66B
YUHAN CORPORATION	+5.38%	3.97B
BETTA PHARMACEUTICALS CO., LTD.	-16.20%	2.55B
INDIVIOR PLC	+21.10%	2.41B
CHANGCHUN BCHT BIOTECHNOLOGY CO.	-26.20%	2.36B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	+19.92%	2.21B
SUPERNUS PHARMACEUTICALS, INC.	+8.15%	1.71B

Specialty & Advanced Pharmaceuticals